RAC1 and breast cancer: From a therapeutic perspective, increasing the RAC1B:RAC1 ratio by stimulating the generation of RAC1B over RAC1 through intervention with the splicing process [27,28] may be a feasible approach to reverse mesenchymal differentiation and eventually reduce metastasis or restore drug-sensitivity in BC.